Interpretation of indeterminate HIV-1 PCR results are influenced by changing vertical transmission prevention regimens

Journal of Clinical Virology

Volumn 95, Issue , 2017, Pages 86-89

  Maritz, Jean ^a   Maharaj, Jayshree Narvin ^a   Cotton, Mark Frederic ^b   Preiser, Wolfgang ^a  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

False positive; Indeterminate result; Infant diagnosis; Misdiagnosis; PCR; Prophylaxis

Indexed keywords

ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIRETROVIRAL THERAPY; ARTICLE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; SERODIAGNOSIS; SOUTH AFRICA; VERTICAL TRANSMISSION; FALSE POSITIVE RESULT; FEMALE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MALE; MOLECULAR DIAGNOSIS; PREGNANCY; PREGNANCY COMPLICATION; PREVENTION AND CONTROL; PROCEDURES; TRANSMISSION; VIROLOGY;

ANTI-HIV AGENTS; FALSE POSITIVE REACTIONS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; SOUTH AFRICA;

EID: 85028908647     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2017.08.013     Document Type: Article

References (17)

1. Violari, A., Cotton, M.F., Gibb, D.M., et al. Early antiretroviral therapy and mortality among HIV-infected infants. N. Engl. J. Med. 359:21 (2008), 2233–2244, 10.1056/NEJMoa0800971.
2. Luzuriaga, K., Tabak, B., Garber, M., et al. Reduced HIV reservoirs after early treatment HIV-1 proviral reservoirs decay continously under sustained virologic control in early-treated HIV-1–infected children. J. Infect. Dis. 210 (2014), 1529–1538 http://jid.oxfordjournals.org/content/210/10/1529.
3. World Health Organization, WHO Consolidated Guidelines on HIV Testing Services, WHO; Geneva, July. http://apps.who.int/iris/bitstream/10665/179870/1/9789241508926_eng.pdf?ua=1&ua=1 (last accessed October, 2016).
4. The 2013 National Antenatal Sentinel HIV Prevalence Survey South Africa, 2013. https://www.health-e.org.za/wp-content/uploads/2016/03/Dept-Health-HIV-High-Res-7102015.pdf (last accessed October, 2016).
5. Statistical release P0302, Mid-year population estimates 2014, Statistics South Africa https://www.statssa.gov.za/publications/P0302/P03022014.pdf (last accessed October, 2016).
6. ® TaqMan HIV-1 Qual Test [package insert]. Branchburg, NJ, Roche, 2010.
7. Maritz, J., Preiser, W., van Zyl, G.U., Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots. J. Clin. Virol. 53:2 (2012), 106–109, 10.1016/j.jcv.2011.12.002.
8. ® TaqMan HIV-1 Qualitative Test, version 2.0 [package insert]. Branchburg, NJ, Roche, 2013.
9. Maritz, J., van Zyl, G.U., Preiser, W., Irreproducible positive results on the Cobas AmpliPrep/Cobas TaqMan HIV-1 Qual test are different qualitatively from confirmed positive results. J. Med. Virol. 86:January (1) (2014), 82–87.
10. Stinson, K., Giddy, J., Cox, V., Burton, R., Ibeto, M., Cragg, C., van Cutsem, G., Hilderbrand, K., Boulle, A., Coetzee, D., Goemaere, E., Reflections on a decade of delivering PMTCT in Khayelitsha, South Africa. S. Afr. J. HIV Med. 15:1 (2014), 30–32 http://www.sajhivmed.org.za/index.php/hivmed/article/view/41/54.
11. National Department of Health, National Consolidated Guidelines for the Prevention of Mother-to-Child Transmission of HIV (PMTCT) and the Management of HIV in Children, Adolescents and Adults. 2014, Department of Health, Pretoria 24 December 2014 http://www.kznhealth.gov.za/family/HIV-Guidelines-Jan2015.pdf.
12. Sherman, G.G., HIV testing during the neonatal period. S. Afr. J. HIV Med., 16(1), 2015, a362, 10.4102/sajhivmed.v16i1.362.
13. Mitchell, C., Dross, S., Beck, I.A., Micek, M.A., Frenkel, L.M., Low concentrations of HIV-1 DNA at birth delays diagnosis, complicating identification of infants for antiretroviral therapy to potentially prevent the establishment of viral reservoirs. Clin. Infect. Dis. 58 (2014), 1190–1193, 10.1093/cid/ciu068.
14. Haeri Mazenderani, A.F., Du Plessis, N.M., Thomas, W.N., Venter, E., Avenant, T., Loss of detectability and indeterminate results: challenges facing HIV infant diagnosis in South Africa's expanding ART programme. S. Afr. Med. J. 104 (2014), 574–577, 10.7196/samj.8322.
15. Feucht, U.D., Forsyth, B., Kruger, M., False-positive HIV DNA PCR testing of infants: implications in a changing epidemic. S. Afr. Med. J. 102:3 Pt. 1 (2012), 149–152 http://www.samj.org.za/index.php/samj/article/view/4951/3886.
16. Haeri Mazanderani, A., Technau, K.-G., Hsiao, N.-Y., Maritz, J., Carmona, S., Sherman, G.G., Recommendations for the management of indeterminate HIV PCR results within South Africa's early infant diagnosis programme. S. Afr. J. HIV Med., 17(1), 2016, a451, 10.4102/sajhivmed.v17i1.451.
17. Mazanderani, A.H., Kufa-chakezha, T., Greyling, D., Goosen, M., Sherman, G., Follow-up analysis of HIV PCR indeterminate results from an early infant diagnosis laboratory in South Africa. Abstract 201, 2nd Biennial Southern African HIV Clinicians Society Conference, April 2016, Sandton, South Africa, 2017.